E-support for Healthcare Processes - ASTHMA (E-ASTHMA)
Recruitment status was: Recruiting
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||E-support for Healthcare Processes - ASTHMA|
- Number of exacerbations. [ Time Frame: 1 year ]Number of exacerbations per year.
|Study Start Date:||October 2011|
|Estimated Study Completion Date:||April 2013|
|Estimated Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|
|Experimental: Asthma - ICT support.||
Other: Self management asthma plan indorsment.
Subjects adherence to asthma self management plan will be monitored through web-based support.
|No Intervention: Asthma, comparator - no ICT support|
A mobile environment to improve the process of an integrated treatment of people with asthma will be identified, developed, introduced and clinically evaluated. The study will include 120 patients diagnosed with asthma that is poorly managed. The study will use the ACT (Asthma Control Test) questionnaire and an evaluation questionnaire that will cover issues regarding the satisfaction of subjects with asthma care offered. Subjects with a PEF meter, will be able to enter the value of PEF (Peak Expiratory Flow).
In addition to this, users can enter values (1) physical activity (type, duration, intensity), and (2) food (type, quantity).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01461642
|Contact: Stanislav Šuškovič, MD, PhD, Prof.||+386 4 2569 email@example.com|
|Contact: Iztok Cukjati||+386 40 186 firstname.lastname@example.org|
|University Clinic of Pulmonary and Allergic Disease||Recruiting|
|Golnik, Slovenia, 4204|
|Contact: Stanislav Šuškovič, MD, PhD, Prof. +386 4 2569 390 email@example.com|
|Contact: Jana Bogataj +386 4 2569 500 firstname.lastname@example.org|
|Sub-Investigator: Sabina Škrgat Kristan, MD, PhD|
|Sub-Investigator: Mateja Marc Malovrh, MD, PhD|
|Sub-Investigator: Matjaž Fležar, MD PhD Doc|
|Sub-Investigator: Mihaela Zidarn, MD, MSci|